Overview
Dr. Allen LaPointe is an Adjunct Associate Professor in Medicine and Faculty Fellow at the Duke-Margolis Center for Health Policy at Duke University. She is a researcher and cardiovascular clinical pharmacist with extensive experience in health outcomes and health services research, evidence synthesis, and the protection of human research subjects. Her clinical and research work have been focused on patient safety, predominately in patients with cardiovascular disease. This includes work in reducing medication errors, improving medication adherence, safely and effectively translating evidence into clinical practice, comparing safety and effectiveness of therapeutics, evaluating risk communication and mitigation strategies, and exploring the interface between health policy and patient safety.
Current Appointments & Affiliations
Adjunct Associate Professor in the Department of Medicine
·
2015 - Present
Medicine, Cardiology,
Medicine
Faculty Fellow, Duke-Margolis Institute for Health Policy
·
2024 - Present
Duke-Margolis Institute for Health Policy,
University Initiatives & Academic Support Units
Recent Publications
Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities.
Journal Article J Pediatr · June 2024 Full text Link to item CiteFacilitating Shared Decision Making Among Black Patients at Risk for Sudden Cardiac Arrest : A Randomized Clinical Trial.
Journal Article Ann Intern Med · May 2023 BACKGROUND: Racial disparities in implantable cardioverter-defibrillator (ICD) implantation are multifactorial and are partly explained by higher refusal rates. OBJECTIVE: To assess the effectiveness of a video decision support tool for Black patients elig ... Full text Link to item CiteCardiac resynchronization therapy outcomes with left ventricular lead concordant with latest mechanical activation: A meta-analysis.
Journal Article Pacing Clin Electrophysiol · August 2022 BACKGROUND: For cardiac resynchronization therapy (CRT), image-guided approaches targeting left ventricular (LV) lead placement at the site of latest mechanical activation had inconsistent outcomes. We examined evidence for improved CRT outcomes when LV le ... Full text Link to item CiteRecent Grants
CF Cooperative Agreement to Support Regulatory Research Related to the 2022 Prescription Drug User Fee Act and Biosimilar User Fee Act (U19)
ResearchAdvisor · Awarded by Food and Drug Administration · 2018 - 2028Accelerating Value-Based Care Impact at the State and National Level
ResearchAdvisor · Awarded by Gary and Mary West Health Policy Center · 2023 - 2027Accelerating Value-Based Care Impact at the State and National Level
ResearchAdvisor · Awarded by Gary and Mary West Health Institute · 2023 - 2027View All Grants
Education, Training & Certifications
Duke University ·
2013
M.H.S.
Purdue University ·
1988
Pharm.D.